NAV
$38.50
AUM
$1.0B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.84
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +10.14% | +3.77% | +9.80% | +19.49% | +16.93% | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | TSM | Taiwan Semiconductor Manufacturing Co Ltd ADR | 11.88% |
| 2 | TCEHY | Tencent Holdings Ltd ADR | 2.30% |
| 3 | ASML | ASML Holding NV ADR | 1.87% |
| 4 | BABA | Alibaba Group Holding Ltd ADR | 1.73% |
| 5 | RHHBY | Roche Holding AG ADR | 1.10% |
| 6 | AZN.L | AstraZeneca PLC | 1.08% |
| 7 | SAP | SAP SE ADR | 1.03% |
| 8 | HSBC | HSBC Holdings PLC ADR | 0.95% |
| 9 | NVO | Novo Nordisk AS ADR | 0.90% |
| 10 | NVS | Novartis AG ADR | 0.88% |
The fund is an actively-managed exchange-traded fund (“ETF”) that blends active and passive investment strategies to optimize costs, tracking and potential return over the fund’s benchmark index, the S&P Classic ADR Composite Index. Under normal market conditions, the fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities of non-U.S. companies with varying market capitalizations.
Inception Date: 2023-05-02